Ji-bing Chen
Guangzhou, 510665, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Irreversible electroporation combined with anti-programmed cell death protein 1 therapy promotes tumor antigen-specific CD8+ T cell response.
Journal: World journal of gastrointestinal oncology
Published: October 04, 2024
Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study.
Journal: Medical gas research
Published: December 31, 2020
A narrative review of hydrogen oncology: from real world survey to real world evidence.
Journal: Medical gas research
Published: October 02, 2020
Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer.
Journal: World journal of clinical cases
Published: August 12, 2020
Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer.
Journal: Medical gas research
Published: June 17, 2020
Cryoablation for liver metastasis from solid pseudopapillary tumor of the pancreas: A case report.
Journal: World journal of clinical cases
Published: October 29, 2019
Irreversible electroporation for liver metastasis from pancreatic cancer: A case report.
Journal: World journal of clinical cases
Published: October 24, 2019
"Real world survey" of hydrogen-controlled cancer: a follow-up report of 82 advanced cancer patients.
Journal: Medical gas research
Published: September 26, 2019
Hydrogen gas therapy induced shrinkage of metastatic gallbladder cancer: A case report.
Journal: World journal of clinical cases
Published: March 02, 2019
Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.
Journal: Immunologic research
Published: November 17, 2017
Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis.
Journal: Oncotarget
Published: November 02, 2017
Last Updated: 09/26/2026